Assenagon Asset Management
ORMP icon

Assenagon Asset Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Assenagon Asset Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,118
Closed -$32K – 1423
2024
Q3 		$32K Sell
13,118
-3,301
-20% -$8.05K ﹤0.01% 1355
2024
Q2 		$42.2K Sell
16,419
-2,240
-12% -$5.32K ﹤0.01% 1397
2024
Q1 		$54.5K Buy
+18,659
New +$52.2K ﹤0.01% 1349
2022
Q2 		– Sell
-385,413
Closed -$3.33M – 1555
2022
Q1 		$3.33M Buy
+385,413
New +$3.95M 0.01% 657

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return